AURA Biopharm, Eurocine Vaccines and Ocuspecto have been announced as the winners of Nordic Stars 2016 Awards. The awards were presented at the conclusion of the Nordic Life Science Days (NLSDays) in Stockholm, which again set a new record for attendance. More than 1 070 delegates representing over 680 companies from 36 countries joined the conference, thus accentuating NLSDays’ role as the premier Nordic life sciences event.
Nordic Stars Awards were introduced in 2013 in special recognition of life science companies in the Nordic region demonstrating outstanding innovation and entrepreneurial skills.
– At SwedenBIO we are proud to present three winners of the Nordic Stars Awards 2016, each being passionate about developing solutions for their respective patient groups. Innovations like these, developed with impressive entrepreneurial spirit all contribute to sustainable healthcare, the theme of this year’s conference program, says Jonas Ekstrand, Director General at SwedenBIO.
This year’s winners are:
AURA Biopharm, Norway
Recently founded AURA Biopharm is developing a treatment for a serious rare autoimmune disease, Antiphospholipid Syndrome. Based in Oslo, but operating virtually and led by an International team of very experienced scientists, managers and experts, AURA Biopharm has developed an exciting collaborative business model with great possibilities to deliver future breakthrough therapies to the market.
Eurocine Vaccines, Sweden
Eurocine Vaccines will soon enter clinical trials with their nasal quadrivalent influenza vaccine particularly aimed for children under the age of 2 years. Based on their proprietary adjuvant technology, the company is targeting a patient population where current vaccines have low preventive effects and recommendations from authorities world-wide are likely to result in a growing market. A vaccine without a needle could no doubt be labelled ”patient centric”.
Ocuspecto has developed and commercialized a novel portable medical device for the examination of the neuro-visual system from the eye to the visual processing in the brain. This ”easy-to-use-almost-anywhere” cloud-based device will provide healthcare professionals with essential information to diagnose, prevent and with increased precision follow up treatments of vision defects, cataract, glaucoma and macular degeneration. Their slogan is ”your vision is our mission” – what else can you expect from a Nordic Star!
Jonas Ekstrand also reflected on highly successful two days:
– When we now conclude the 4th annual conference in a row with more delegates than ever, Nordic Life Science Days manifests itself as the premium conference, partnering and networking event within life science in Northern Europe. Join us next year again when the conference will be held in Malmö-Copenhagen, the heart of Medicon Valley.
Nordic Life Science Days 2016 in brief
Registered Delegates: 1,070
Registered Companies: > 680
Countries Represented: 36
Partnering Meeting Requests: > 12,000
Partnering Meetings Scheduled: >2,200
We are moving south for next year
Join us next year when Nordic Life Science Days are held in Malmö – Copenhagen on September 12-14, 2017
NLSDays was founded in 2012 and has grown rapidly to become the largest Nordic partnering conference for the global life science industry.
Among the investors and big pharma registered for the meeting are AbbVie, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen, Johnson & Johnson, Eli Lilly and Company, MSD, Roche, Sanofi, Nasdaq, Vator Securities, Aporia, MVM Life Sciences Partners, Novo seeds, DNB, Hadean Ventures, Sunstone, Seventure Partners, Industrifonden, HealthCap, Sciety, and Trout Group.
In addition to partnering, NLSDays also offers an exhibition and a seminar program. Speakers include senior representatives from the global life science companies, investors, and academic leaders who will all share their expertise and views for the future.
Läs mer på MyNewsDesk